News | Cardiac Diagnostics | July 01, 2016

Anabolic Steroid Abuse May Increase Arrhythmia, Stroke Risk

Study shows that people with the inherited heart condition ARVC could be at particular risk

anabolic steroid abuse, ARVC, arrhythmia, stroke, British Cardiovascular Society conference

July 1, 2016 — Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk of developing heart conditions such as left ventricular hypertrophy.

Now research, part-funded by the British Heart Foundation and presented at this year’s British Cardiovascular Society conference, June 6-8 in Manchester, England, has shown that for some people misusing steroids can be particularly dangerous.

A team of researchers from the University of Birmingham (U.K.) have found evidence to suggest that, when taken by people with the inherited heart condition arrhythmogenic right ventricular cardiomyopathy (ARVC), steroids could lead to changes in heart muscle structure and problems with the heart’s electrical signals. These changes would then increase the likelihood that people taking steroids would suffer from atrial fibrillation, an abnormal heart rhythm disorder which is itself a major cause of stroke.

ARVC is caused by a mutation in one or more genes responsible for producing the proteins that hold the heart muscle together. The researchers gave dihydrotestosterone, an anabolic steroid commonly used to enhance athletic performance, to mice with a deficiency in one of these same proteins.

They found that, in these hearts, the electrical signal that tells the heart when to beat travelled around the heart more slowly than usual. This slowing down of electrical activity put these hearts at greater risk of dangerous abnormal heart rhythms, such as atrial fibrillation.

It is estimated that hundreds of thousands of people in the United Kingdom have used anabolic steroids for non-medical purposes in their lifetime. Anabolic steroids are prescription-only medicines that are sometimes taken without medical advice to increase muscle mass and improve athletic performance. If used in this way, they can cause serious side effects and addiction.

Larissa Fabritz, senior author and reader in cardiovascular sciences at the University of Birmingham, said, “With one in every five men joining a gym in the U.K. using performance-enhancing anabolic steroids the misuse of steroids is fast becoming an emerging global health problem. Our results show that the misuse of steroids could explain why seemingly healthy individuals are suffering from serious heart problems.”

Jeremy Pearson, associate medical director at the British Heart Foundation, said, “This study reinforces the evidence that using anabolic steroids can have untoward and possibly dangerous side effects, particularly in those who, often unknowingly, have heart problems.”

For more information: www.bcs.com/conference

Related Content

Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init